Clinical Trial: ED50 of Dexmedetomidine as an Adjuvant to 0.5% Hyperbaric Bupivacaine 12.5 mg for Spinal Anesthesia in Hip and Knee Surgery: An Up-and-Down Method Approach

U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07144215) titled 'ED50 of Dexmedetomidine as an Adjuvant to 0.5% Hyperbaric Bupivacaine 12.5 mg for Spinal Anesthesia in Hip and Knee Surgery: An Up-and-Down Method Approach' on Aug. 20.

Brief Summary: Determine ED50 dexmedetomidine adjuvant that can provide spinal anesthetic sensory blockade duration of 200 minutes on knee and pelvis surgery with up-and-down method.

Study Start Date: Feb. 01

Study Type: INTERVENTIONAL

Condition: Knee Surgery Pelvic Surgery Spinal Aneshtesia

Intervention: DRUG: Bupivacain hyperbaric 0.5% 12.5 mg and dexmedetomidine 3 mcg

Patient received spinal injection of Bupivacain hyperbaric 0.5% 12.5 mg and dexmedetomidin...